GlassScriptPhysician profile
Alexander T Sleder
NPI 1699876441
$3,898.70
in general payments reported to CMS, 2019-2025
45 companies · $571 in 2025
The $571 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,315 · 2020: $338 · 2022: $450 · 2023: $744 · 2024: $480 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,794.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $829.44 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $470.02 | 2019-2023 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $287.22 | 2019-2020 | |
| Corium, LLC | $234.99 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $197.33 | 2019-2025 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $194.24 | 2019-2024 | Gardasil 9, Vaxelis, Gardasil |
| Pfizer INC. | $164.76 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $135.83 | 2022 | |
| Novartis Pharmaceuticals Corporation | $125.57 | 2022-2023 | |
| Allergan, INC. | $125.00 | 2020 | |
| Gilead Sciences, INC. | $95.15 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $91.97 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $68.74 | 2023-2024 | Jornay Pm |
| Dynavax Technologies Corporation | $67.21 | 2023-2025 | Heplisav-B |
| Tris Pharma INC | $58.23 | 2019-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Sleder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.